SAFE-HEaRt: A pilot study assessing the cardiac safety of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function.
暂无分享，去创建一个
C. Isaacs | M. Tan | S. Swain | M. Srichai | F. Asch | P. Pohlmann | A. Barac | K. Smith | M. Hofmeyer | C. Dang | A. Shajahan-Haq | F. Lynce | R. Warren | R. Nunes | C. Gallagher | X. Geng | A. Yu | P. Herbolsheimer | P. Timothee | A. Cunningham